Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

RCKT stock hub

Rocket Pharmaceuticals, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

RCKTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

396.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

RCKT

In the news

Latest news · RCKT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-64.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-38

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All RCKT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001281895
Company name	Rocket Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	77313F106
Employees	202
Employees Change	-97%
Employees Change Percent	-32.44
Enterprise value	$276.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US77313F1066
Last refreshed	2026-05-10
Market cap	$396.4M
Market cap category	Small-Cap
Price	$3.63
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	RCKT
Website	https://www.rocketpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-52.82%
FCF yield	-45.36%
P/B ratio	1.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-209.4M
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Profit Per Employee	$-1M
ROA	-35.14
Roa5y	-27.79
ROCE	-81.49
ROE	-64.41
Roe5y	-49.34
ROIC	-37.96

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-45.84%
Cagr3y	-44.29%
Cagr5y	-39.23%
EPS Growth Quarters	5
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$285.4M
Cash	$144.4M
Current Assets	$149.8M
Current Liabilities	$24.5M
Debt	$24.8M
Debt Equity	$0.1
Equity	$238M
Interest Coverage	-112.4
Liabilities	$47.4M
Long Term Assets	$135.6M
Long Term Liabilities	$22.9M
Net Cash	$119.6M
Net Cash By Market Cap	$30.18
Net Cash Growth	-59.15%
Net Debt Equity	$-0.5
Tangible Book Value	$173.7M
Tangible Book Value Per Share	$1.59
WACC	7.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.12
Net Working Capital	$-16.1M
Quick ratio	5.9
Working Capital	$125.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-12.83%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-45.82%
200-day SMA	3.56
3Y total return	-82.71%
50-day SMA	4.06
50-day SMA vs 200-day SMA	50over200
5Y total return	-91.71%
All Time High	67.48
All Time High Change	-94.62%
All Time High Date	2021-02-08
All Time Low	2.19
All Time Low Change	65.75%
All Time Low Date	2025-05-27
ATR	0.25
Beta	0.52
Beta1y	0.68
Beta2y	1.51
Ch YTD	3.42
High	3.96
High52	7.39
High52 Date	2025-05-12
High52ch	-50.88%
Low	3.53
Low52	2.19
Low52 Date	2025-05-27
Low52ch	65.75%
Ma50ch	-10.59%
Premarket Change Percent	-0.27
Premarket Price	$3.66
Premarket Volume	7,074
Price vs 200-day SMA	1.85%
RSI	47.22
RSI Monthly	34.27
RSI Weekly	47.24
Sharpe ratio	0.03x
Sortino ratio	0.09
Total Return	-12.83%
Tr YTD	3.42
Tr1m	4.31%
Tr1w	1.97%
Tr3m	14.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	14
Analyst Count Top	7
Analyst Price Target Top	$53.67
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.44
Operating Income	$-212.6M
Price target	$29.73
Price Target Change	$719
Price Target Change Top	$1,379

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	88,717,044%
Float Percent	81.25%
Net Borrowing	-1,000
Shares Insiders	2.44%
Shares Institutions	69.24%
Shares Out	109,193,549
Shares Qo Q	0.31%
Shares Yo Y	12.83%
Short Float	21.5%
Short Ratio	4.02
Short Shares	17.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-215M
Average Volume	2,135,553.95x
Bv Per Share	2.18
CAPEX	$-169,000
Ch1m	4.31
Ch1w	1.97
Ch1y	-45.82
Ch3m	14.87
Ch3y	-82.71
Ch5y	-91.71
Ch6m	14.51
Change	-1.09%
Change From Open	-3.71
Close	3.67
Days Gap	2.72
Depreciation Amortization	10,182,000
Dollar Volume	13,387,193.2
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-212.6M
EBITDA	$-202.5M
EPS	$-1.88
F Score	1
FCF	$-179.8M
FCF EV Yield	-64.96x
FCF Per Share	$-1.65
Financing CF	147,000
Fiscal Year End	December
Founded	1,999
Goodwill	39,154,000
Investing CF	179,250,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	3.69
Ma150ch	-1.57%
Ma20	3.66
Ma20ch	-0.87%
Net CF	-221,000
Next Earnings Date	2026-08-06
Open	3.77
Optionable	Yes
Position In Range	23.26
Ppne	69,453,000
Pre Close	3.67
Price Date	2026-05-08
Ptbv Ratio	2.28
Relative Volume	1.73x
Share Based Comp	35,221,000
Tr6m	14.51%
Us State	New Jersey
Volume	3,687,932

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does RCKT pay a dividend?

Capital-return profile for this ticker.

Performance

RCKT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns RCKT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+69.2%

Float: +81.2% of shares outstanding

Insider ownership

+2.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

RCKT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.2

Neutral momentum band

Price vs 200-day MA

+1.9%

50/200-day relationship not available

Beta (5Y)

0.52

Less volatile than the market

Sharpe ratio

0.03

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About RCKT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current RCKT stock rating?

Rocket Pharmaceuticals, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full RCKT analysis?

The full report lives at /stocks/RCKT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for RCKT?

The latest report frames RCKT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the RCKT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.